Cargando…
CTLA-4 positive breast cancer cells suppress dendritic cells maturation and function
Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), a potent immunoregulatory molecule, can down-regulate T-cell activation and inhibit anti-tumor immune response. This study showed that LPS-stimulated human dendritic cells (DCs) decreased the expression of HLA-DR, CD83 and costimulatory molecules...
Autores principales: | Chen, Xi, Shao, Qianqian, Hao, Shengnan, Zhao, Zhonghua, Wang, Yang, Guo, Xiaofan, He, Ying, Gao, Wenjuan, Mao, Haiting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355131/ https://www.ncbi.nlm.nih.gov/pubmed/28099147 http://dx.doi.org/10.18632/oncotarget.14626 |
Ejemplares similares
-
CTLA4 is expressed on mature dendritic cells derived from human monocytes and influences their maturation and antigen presentation
por: Wang, Xiong B, et al.
Publicado: (2011) -
Epigenetically modulated FOXM1 suppresses dendritic cell maturation in pancreatic cancer and colon cancer
por: Zhou, Zhongshi, et al.
Publicado: (2019) -
S43. Dendritic cell vaccination combined with CTLA4 blockade
por: Thielemans, K, et al.
Publicado: (2014) -
CTLA4-Ig immunosuppressive activity at the level of dendritic cell/T cell crosstalk
por: Mayer, Edda, et al.
Publicado: (2013) -
Lymphatic endothelial cells attenuate inflammation via suppression of dendritic cell maturation
por: Christiansen, Ailsa J., et al.
Publicado: (2016)